Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) - 5-tert-butyl-pyrazol-1-yl] benzoic acid

Details for Australian Patent Application No. 2009211215 (hide)

Owner AstraZeneca AB

Inventors Tomkinson, Gary Peter; Scott, James Stewart; Stocker, Andrew; Whittamore, Paul Robert Owen; Packer, Martin

Agent Davies Collison Cave

Pub. Number AU-B-2009211215

PCT Pub. Number WO2009/098501

Priority 61/082,293 21.07.08 US; PCT/ GB2008/000454 11.02.08 GB; 108/2008 04.02.08 PK

Filing date 3 February 2009

Wipo publication date 13 August 2009

Acceptance publication date 3 November 2011

International Classifications

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/098501 Priority application(s): WO2009/098501

3 November 2011 Application Accepted

  Published as AU-B-2009211215

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009211224-Nanoparticle conjugates

2009211210-Load transportation system